Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine
Bucheon-si, Gyeonggi-do, 420-767, South Korea
NCT Number: NCT01758965
The aim of this study is to assess the effect of Surgicel® Fibrillar as adjuvant treatment to H2RA on preventing ulcer bleeding after ESD for gastric epithelial tumors
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Bucheon-si, Gyeonggi-do, 420-767, South Korea
(1) Study group: combination with Surgicel® Fibrillar and H2RA (2) Control group: monotherapy with PPI 3. Sample size : 157 4. Result
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
monotherapy of PPI
combination therapy of H2RA and surgicel
Time frame: 1 year
Soonchunhyang University Hospital
Other
Surgicel® (Fibrillar) for Preventing Delayed Bleeding After ESD in Stomach: A Prospective Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02205047
Digestive System Diseases, Digestive System Neoplasms
Ghent, Flanders, Belgium
View Trial DetailsNCT02337673
Airway Obstruction, Digestive System Diseases
Mainz, Rheinland-Pfalz (Rhineland-Palatinate), Germany
View Trial DetailsNCT02158988
Abdominal Neoplasms, Digestive System Diseases
Berlin, Germany
View Trial DetailsNCT01443065
Adenocarcinoma, Carcinoma
Villejuif, France
View Trial Details